EMA approves two antibody treatments for severe COVID-19
The European Medicines Agency has approved Ronapreve and Regkirona as antibody therapies for severe COVID-19. These are the first monoclonal antibody medicines to receive a positive opinion for the disease.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthEMA approves two antibody treatments for severe COVID-19
Sign in or subscribeBrowse free archive reportsThe European Medicines Agency has approved Ronapreve and Regkirona as antibody therapies for severe COVID-19. These are the first monoclonal antibody medicines to receive a positive opinion for the disease.